ECSP088079A - Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado - Google Patents

Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado

Info

Publication number
ECSP088079A
ECSP088079A EC2008008079A ECSP088079A ECSP088079A EC SP088079 A ECSP088079 A EC SP088079A EC 2008008079 A EC2008008079 A EC 2008008079A EC SP088079 A ECSP088079 A EC SP088079A EC SP088079 A ECSP088079 A EC SP088079A
Authority
EC
Ecuador
Prior art keywords
edulcorant
oral formulations
highly dosed
include ondansetron
ondansetron
Prior art date
Application number
EC2008008079A
Other languages
English (en)
Spanish (es)
Inventor
Junior Dante Alario
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37604052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088079(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Publication of ECSP088079A publication Critical patent/ECSP088079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
EC2008008079A 2005-07-05 2008-01-04 Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado ECSP088079A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0502736-5A BRPI0502736A (pt) 2005-07-05 2005-07-05 formulações orais de ondansetrona com sabor residual mascarado

Publications (1)

Publication Number Publication Date
ECSP088079A true ECSP088079A (es) 2008-02-20

Family

ID=37604052

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008079A ECSP088079A (es) 2005-07-05 2008-01-04 Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado

Country Status (3)

Country Link
BR (1) BRPI0502736A (pt)
EC (1) ECSP088079A (pt)
WO (1) WO2007003020A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401086B1 (it) * 2010-07-19 2013-07-12 Farmalip S R L Dolcificante.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
AU2002255196A1 (en) * 2002-04-18 2003-10-27 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
WO2007003020A1 (en) 2007-01-11
BRPI0502736A (pt) 2007-02-27

Similar Documents

Publication Publication Date Title
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
MY157772A (en) Antibody formulation
EA201290984A1 (ru) Гелеобразные фармацевтические композиции, препятствующие злоупотреблению
BRPI0506779A (pt) formulação de sorvete, e, sorvete
CR20110110A (es) Composicion farmaceutica
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
NO20075111L (no) Farmasoytisk sammensetning
MY161595A (en) Oral care compositions
AR054595A1 (es) Formulaciones/composiciones farmaceuticas de guanfacina apropiadas para forma de administracion diaria en una unica dosis
WO2010021607A3 (en) Pharmaceutical formulation
EA201170512A1 (ru) Композиция для перорального введения
TR200900878A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
ECSP10010576A (es) Formulaciones orales e inyectables de compuestos de tetraciclina
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
IN2012DN00359A (pt)
MX2010004899A (es) Conjugados de neurturina novedosos para uso farmaceutico.
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
GT200800297A (es) Formulaciones galenicas de alisquireno e hidroclorotiazida
CO6321223A2 (es) Formulacion farmaceutica solida que contiene ciclostazol
UY29989A1 (es) Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones
ECSP088079A (es) Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
IL191670A0 (en) Compounds for the inhibition of apoptosis